CRS Clinical Research Services Berlin GmbH
About CRS Clinical Research Services Berlin GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
13
BioNTech SE
2
Alzeca Biosciences, Inc.
1
Boehringer Ingelheim
1
EirGenix, Inc.
1
Idorsia Pharmaceuticals Ltd.
1
Ipsen
1
Janssen Research & Development, LLC
1
Clinical Trials at CRS Clinical Research Services Berlin GmbH
During the past decade, CRS Clinical Research Services Berlin GmbH conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate
2016-02-01
2016-08-01
Completed
30
First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080
2016-07-22
2017-08-23
Completed
88
Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction
2017-02-15
2017-07-19
Completed
15
First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845
2017-02-13
2018-03-29
Completed
70
Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116
2017-04-27
2018-01-31
Terminated
32
Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
2017-07-17
2019-01-23
Completed
71
BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect
2017-07-18
2018-07-27
Completed
72
BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food Effect
2018-03-21
2019-02-11
Completed
72
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CRS Clinical Research Services Berlin GmbH" #1 sponsor was "Bayer" with 13 trials, followed by "BioNTech SE" with 2 trials
sponsored, "Alzeca Biosciences, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "EirGenix, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CRS Clinical Research Services Berlin GmbH"
#1 collaborator was "Orion Corporation, Orion Pharma" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator, "Sacura GmbH" with 1 trials as a collaborator and "pharmtrace klinische Entwicklung GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at CRS Clinical Research Services Berlin GmbH
According to Clinical.Site data, the most researched conditions in "CRS Clinical Research Services Berlin GmbH" are
"Endometriosis" (3 trials), "Healthy" (3 trials), "COVID-19" (2 trials), "Clinical Trials, Phase I as Topic" (2 trials) and "SARS-CoV-2 Infection" (2 trials). Many other conditions were trialed in "CRS Clinical Research Services Berlin GmbH" in a lesser frequency.
Clinical Trials Intervention Types at CRS Clinical Research Services Berlin GmbH
Most popular intervention types in "CRS Clinical Research Services Berlin GmbH" are "Drug" (18 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Itraconazole" (5 trials), "BAY1841788 (ODM-201)" (2 trials), "BAY1902607" (2 trials) and "BNT162b2" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CRS Clinical Research Services Berlin GmbH
The vast majority of trials in "CRS Clinical Research Services Berlin GmbH" are
11 trials for "Male" genders, 6 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at CRS Clinical Research Services Berlin GmbH
Currently, there are NaN active trials in "CRS Clinical Research Services Berlin GmbH".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in CRS Clinical Research Services Berlin GmbH,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in CRS Clinical Research Services Berlin GmbH, 18 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".